TL;DR

Anthropic will not begin marketing its flotation before mid-October, with the listing itself now expected in the closing days ahead of the US midterm elections. The prospectus, once pencilled in for this week, has moved to late September. Investors have floated a figure of $2 trillion for the company.

What actually moved

The slippage looks procedural rather than ominous. A $15bn revolving credit line is being finalised, and analysts — those at the banks arranging the financing included — are due in front of management once it closes. Most issuers allow several weeks to pass after that step before a prospectus goes out. Anthropic is expected to compress the gap, on the reasoning that the analysts covering it already know the business well. Morgan Stanley is on the deal alongside Citi, JPMorgan and Goldman Sachs. The company declined to say anything.

The scale of it

At the number investors have been discussing, this would rank among the largest offerings ever attempted and function as a direct read on whether public markets will pay frontier-lab prices. A benchmark already exists. June’s SpaceX float set a record at $1.77 trillion. OpenAI is expected to follow, which raises the odds of two of the three leading labs pricing within months of one another — and of both being valued in a market that has never had to work out what a research laboratory is worth.

Looking forward

Two threads matter from a UK vantage point. The first is exposure. British pension and tracker funds will end up holding these listings whether or not anyone consciously took a view on AI risk, and the concentration warnings ratings agencies are now issuing about AI suppliers apply to shareholders as squarely as to customers. The second is timing. Nscale, the British AI cloud company claiming £81bn of contracted revenue, is working towards its own listing in roughly the same window and will be priced against whatever multiple Anthropic sets. A subdued debut in New York makes the London deal harder to place; an overheated one makes scepticism expensive.